Correlation Between Summit Therapeutics and Morgan Stanley
Can any of the company-specific risk be diversified away by investing in both Summit Therapeutics and Morgan Stanley at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Summit Therapeutics and Morgan Stanley into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Summit Therapeutics PLC and Morgan Stanley Direct, you can compare the effects of market volatilities on Summit Therapeutics and Morgan Stanley and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Summit Therapeutics with a short position of Morgan Stanley. Check out your portfolio center. Please also check ongoing floating volatility patterns of Summit Therapeutics and Morgan Stanley.
Diversification Opportunities for Summit Therapeutics and Morgan Stanley
-0.04 | Correlation Coefficient |
Good diversification
The 3 months correlation between Summit and Morgan is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Summit Therapeutics PLC and Morgan Stanley Direct in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Morgan Stanley Direct and Summit Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Summit Therapeutics PLC are associated (or correlated) with Morgan Stanley. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Morgan Stanley Direct has no effect on the direction of Summit Therapeutics i.e., Summit Therapeutics and Morgan Stanley go up and down completely randomly.
Pair Corralation between Summit Therapeutics and Morgan Stanley
Given the investment horizon of 90 days Summit Therapeutics PLC is expected to generate 6.37 times more return on investment than Morgan Stanley. However, Summit Therapeutics is 6.37 times more volatile than Morgan Stanley Direct. It trades about 0.14 of its potential returns per unit of risk. Morgan Stanley Direct is currently generating about 0.13 per unit of risk. If you would invest 1,747 in Summit Therapeutics PLC on November 6, 2024 and sell it today you would earn a total of 251.00 from holding Summit Therapeutics PLC or generate 14.37% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.0% |
| Values | Daily Returns |
Summit Therapeutics PLC vs. Morgan Stanley Direct
Performance |
| Timeline |
| Summit Therapeutics PLC |
| Morgan Stanley Direct |
Summit Therapeutics and Morgan Stanley Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Summit Therapeutics and Morgan Stanley
The main advantage of trading using opposite Summit Therapeutics and Morgan Stanley positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Summit Therapeutics position performs unexpectedly, Morgan Stanley can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Morgan Stanley will offset losses from the drop in Morgan Stanley's long position.| Summit Therapeutics vs. Nkarta Inc | Summit Therapeutics vs. Cullinan Oncology LLC | Summit Therapeutics vs. Kezar Life Sciences | Summit Therapeutics vs. Kronos Bio |
| Morgan Stanley vs. Addus HomeCare | Morgan Stanley vs. Aquestive Therapeutics | Morgan Stanley vs. Alphatec Holdings | Morgan Stanley vs. Amgen Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |